Table 3.
SNM vs BonT-A | |||||||
---|---|---|---|---|---|---|---|
| |||||||
Year | Δ Cost | Δ QALY Mean | Cost/QALY | ||||
|
|
||||||
Base Case | Low Range | High Range | Base case | Low Range | High Range | ||
1 | $7237 | $7574 | $6709 | 0.05 | $144 067 | $150 769 | $133 558 |
2 | $4318 | $4884 | $3591 | 0.09 | $44 837 | $50 708 | $37 288 |
4 | −$651 | $277 | −$1691 | 0.19 | SNM Dominant | $1436 | SNM Dominant |
5 | −$2775 | −$1701 | −$3941 | 0.24 | SNM Dominant | ||
10 | −$9402 | −$7698 | −$11 129 | 0.51 |
SNM vs. OMT | |||||||
---|---|---|---|---|---|---|---|
| |||||||
Year | Δ Cost | Δ QALY Mean | Cost/QALY | ||||
|
|
||||||
Base Case | Low Range | High Range | Base Case | Low Range | High Range | ||
1 | $8878 | $8812 | $9008 | 0.19 | $45 999 | $45 655 | $46 672 |
2 | $5888 | $5847 | $6029 | 0.38 | $15 130 | $15 024 | $15 491 |
4 | $348 | $335 | $523 | 0.76 | $455 | $438 | $684 |
5 | −$2233 | −$2236 | −$2039 | 0.94 | SNM Dominant | ||
10 | −11 447 | −$11 347 | −$11 246 | 1.76 |
QALY: quality-adjusted life years; SNM: sacral-neuromodulation; BonT-A: botulinum-toxin-A; OMT: optimized medical-therapy.